Richard Francis

1 week ago | en.globes.co.il | Richard Francis |Gali Weinreb

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) held an "Innovation and Strategy Day" today, in which it discussed the future of its (non-generic) biopharmaceutical activity. The company sees revenue from its three leading drugs: Austedo, for treating involuntary movements; migraine prevention treatment Ajovy; and long-acting schizophrenia treatment Uzedy, reaching at least $5 billion by 2030. This compares with $2 billion for the three products combined in 2024.

Feb 2, 2025 | en.globes.co.il | Richard Francis |Shiri Habib-Valdhorn

The quarterly and annual financials of Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) released last Wednesday sent the company’s share price tumbling 13.9% on the day, and the slide continued on the following days as well. At the close in New York on Friday, Teva, headed by Richard Francis, was at $17.73, giving it a market cap of $20.2 billion, representing a fall of more than $4 billion within three sessions. The market’s disappointment was provoked by Teva’s guidance for 2025.

Sep 30, 2024 | bdonline.co.uk | Richard Francis

Richard Francis takes a look at how wider changes in ESG are further challenging regulation and conventional business practice, suggesting that bio-based materials and processes represent a risk-reducing, value-adding trajectory for the future Building performance expectations are changing rapidly, making a bio-based model attractive for futureproofing and anticipating the “issue evolution” of environmental, social and governance (ESG) standards.

Sep 16, 2024 | bdonline.co.uk | Richard Francis

Richard Francis examines the factors holding back the adoption of bio-based materials There is no question that there is a newfound interest in building materials that are more local, minimally processed, regenerative, and health-promoting. In many respects, the built environment seems to be “catching up” with credentials promoted in other industries. Despite the enthusiasm for – and greater use of – bio-based materials, many hurdles remain.

Sep 2, 2024 | bdonline.co.uk | Richard Francis

Richard Francis explores the implications and applications of a bio-based approach to buildings By bio-based, we refer to buildings constructed of natural materials (wood, bamboo, algae, etc.) or those that mimic biological processes (for example, storing energy and water or biodegrading without harm). The term “bio revolution” is often discussed in other industries, and there is every reason to believe it is coming to construction – in fact, it is already here.